Higher doses of retatrutide produced significant weight loss, with Phase 2 trials reporting average reductions of about 24% of body weight after 48 weeks
Its product portfolio includes treatments for multiple sclerosis, asthma, pain, cancer and infectious diseases, among other conditions
Tirzepatide is a medication used for type 2 diabetes, and under the brand name Zepbound, for chronic weight management to help manage blood sugar levels and support weight loss in certain individuals
GLP-1 receptors are distributed throughout the digestive tract, and their activation affects motility patterns in the oesophagus, stomach, and intestines
Hill, J
Wegovy injection: The recommended maintenance dose is 2.4 mg